Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
USE OF TRIFUNCTIONAL BISPECIFIC AND TRISPECIFIC ANTIBODIES FOR THE TREATMENT OF MALIGNANT ASCITES

No-Receipt date 2009-03595 - 19/10/2009
No-Filing date 20090800030 - 19/10/2009
No-Granting date 8000320 - 27/04/2010
No-EPO application date -
No-EPO granting date -
Gazette No-Publication date of application 3/2010 - 21/04/2010
Gazette No-Publication date of granted patent 4/2010 - 13/05/2010
Expiration date 21/04/2024
Kind of title Supplementary Protection Certificate for Medicinal Products
Legal status NOT VALID
Priorities DE1004343704/09/2000/DE
Active Substance of Supplementary Certificates REMOVAB-CATUMAXOMAB

IPC Classification

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20050401856

Owners
CodeFirstnameSurnameAddressTownZIPCountry
312537 TRION PHARMA GMBH FRANKFURTER RING 193A,MUNCHEN, GERMANY80807 GERMANY

Inventors
CodeFirstnameSurname
328019 LINDHOFER, HORST, DR.

Representatives
CodeFirstnameSurnameAddressTownZip
25MARIAATHANASIADOUKOUMPARI 2ATHINA (ATTIKIS)10674

Contact
CodeFirstnameSurnameAddressTownZipCountry
4007ELENIPAPAKONSTANTINOUKOUMPARI 2ATHINA (ATTIKIS)10674 GREECE

Owners History

Title Instruments
DateOperationDescreption
4/7/2022 12:00:00 AMΈκπτωση Κύριων Τίτλων (79602) ΕΚΠΤΩΣΕΙΣ 03/2022 - Αρ. Πρωτ. ΓΔ 839 / 07.04.22

Payments history
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015